TrialPath

Find a study

Browse recruiting studies near you — free to check, always your choice.

Match me to a study

834 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

  • Parkinson's disease

    Exercise Neuroprotection in Parkinson's Disease

    Testing whether exercise changes inflammation in people with Parkinson’s

    📍 Gait and Balance Laboratory, 217 Bigelow Health Sciences Building, UNLV · Las Vegas, NV · Get directions →

    The purpose of this study is to explore the relationships of exercise on inflammation in the body of older adults and people with Parkinson's disease (PD). This is important research for older adults but is especially important for people with PD because neuroinflammation is the main pathological mechanism that is responsible for neuron cell death in this neurodegenerative disease.

    ✓ Study care freeAges 30–85Learn more →
  • COPD (chronic lung disease)

    A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

    Testing two doses of a medicine versus placebo for COPD symptoms

    📍 Research Site · Birmingham, AL · +39 more US sites · Get directions →

    This Phase IIb dose-ranging study will evaluate the efficacy and safety of 2 different doses of AZD6793 compared with placebo tablets in participants with moderate to very severe chronic obstructive pulmonary disease.

    ✓ Study care freePhase 2Ages 40+Learn more →
  • Sickle cell disease

    Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell Trait

    Comparing bone loss, physical function, and frailty in older women with sickle cell trait

    📍 UConn Health · Farmington, CT · Get directions →

    This is a cross-sectional, clinical research study comparing postmenopausal women of African Descent (AD) with different hemoglobin genotypes: normal and sickle cell trait (SCT). This research study has two purposes.

    ✓ Study care freeAges 50+WomenLearn more →
  • Parkinson's disease

    Exercise to Improve Sleep in Parkinson's Disease

    Testing whether different types of exercise improve sleep in Parkinson’s

    📍 Jewish Rehabilitation Hospital · Laval, Quebec · Get directions →

    This study will investigate the impact of three common exercise modalities, cardiovascular, resistance, and multimodal (i.e., a combination of the previous two) training, on sleep quality and architecture in persons with Parkinson's disease (PD). Furthermore, the project will investigate whether the potential positive exercise-induced changes in sleep are associated with improvements in different quality of life (QoL)-related aspects.

    ✓ Study care freeAges 40+Learn more →
  • Kidney disease

    Oral Intradialytic Amino Acid Supplementation to Vitalize End-stage Kidney Disease Patients on Hemodialysis

    Testing amino acid supplements during hemodialysis for fatigue and thinking in end-stage kidney

    📍 The University of Texas Health Science Center at San Antonio · San Antonio, TX · Get directions →

    The study will test and compare the efficacy of a single essential amino acid valine with a combination of essential amino acids (EAA) supplement on fatigue, frailty, and cognitive function in end-stage kidney disease (ESKD) patients undergoing hemodialysis (HD) treatment.

    ✓ Study care freeEarly Phase 1Ages 18–64Learn more →
  • Kidney disease

    📍 Mayo Clinic in Arizona · Scottsdale, AZ · +4 more US sites · Get directions →

    The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and therapeutic activity of GI-102 as a single agent and in combination with conventional anti-cancer drugs, pembrolizumab or trastuzumab deruxtecan(T-DXd) over a range of advanced and/or metastatic solid tumors.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • Kidney disease

    A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)

    Testing whether empagliflozin is safe and helps children with chronic kidney disease

    📍 University of Alabama at Birmingham · Birmingham, AL · +29 more US sites · Get directions →

    This study is open to children aged 2 to 17 with chronic kidney disease (CKD). The purpose of this study is to find out if a medicine called empagliflozin helps children and adolescents with CKD.

    ✓ Study care freePhase 3Ages 2–17Learn more →
  • Parkinson's disease

    Parkinson's Foundation PD GENEration Genetic Registry

    Building a central database of genetic data for people with Parkinson’s to support future research

    📍 University of Alabama Birmingham · Birmingham, AL · +39 more US sites · Get directions →

    Development of a central repository for PD-related genomic data for future research.

    ✓ Study care freeAges 18+Learn more →
  • Multiple sclerosis (MS)

    📍 Washington University in St. Louis · St Louis, MO · Get directions →

    This study involves a Positron Emission Tomography (PET) scan using a new investigational radioactive tracer, \[18F\]-FZTA, to detect inflammation in the brain. The tracer will be tested in healthy younger adults and individuals with Multiple Sclerosis.

    ✓ Study care freeAges 18+Learn more →
  • COPD (chronic lung disease)

    Predicting Acute Exacerbations of COPD Using Wearable Devices and Remote Monitoring Technology With AI/ML Models

    Testing if wearable devices and AI can predict COPD flare-ups

    📍 McGill University Health Centre · Montreal, Quebec · Get directions →

    This study is aimed to collect real-time physiological data using two wearable devices (a biometric ring and a biometric wristband), daily lung mechanical measurements by a handheld oscillometer, and participant-reported symptoms in patients with COPD remotely from their home environment. The data will be used to train and validate artificial intelligence and machine learning (AI/ML) models to predict COPD exacerbations in advance of their actual occurrence.

    ✓ Study care freeAges 40+Learn more →
  • Parkinson's disease

    Daily Amino Acid Supplementation for People With Parkinson's Disease

    Testing whether a daily amino acid supplement improves nutrition in adults with Parkinson’s disease

    📍 University of Connecticut · Storrs, CT · Get directions →

    The goal of this clinical trial is to learn if a tailored amino acid supplement works to help adults living with Parkinson's disease to improve nutrition, metabolic function, body composition, and physical and mental function. The main questions it aims to answer are: Does the tailored amino acid supplement increase essential amino acids (nutritional status)?

    ✓ Study care freeAges 50–80Learn more →
  • Multiple sclerosis (MS)

    📍 Shirley Ryan AbilityLab · Chicago, IL · Get directions →

    The purpose of this study is to to explore the safety and efficacy of the EXOPULSE Mollii suit, a full-body electrostimulation suit, for individuals with neurological or neuromuscular conditions that cause spasticity, hyperreflexia, and/or pain.

    ✓ Study care freeAges 18–75Learn more →
  • Kidney disease

    Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD

    Studying how blood vessel and nerve control during exercise works in people with chronic kidney

    📍 Emory Clinic · Atlanta, GA · +1 more US site · Get directions →

    The goals of this project are to investigate the mechanisms and potential therapies related to exercise capacity in persons with chronic kidney disease (CKD).

    ✓ Study care freePhase 2Ages 40–75Learn more →
  • COPD (chronic lung disease)

    Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency

    Testing how a genetic change in alpha-1 antitrypsin affects immune and lung responses to a pneumonia

    📍 University of Alabama at Birmingham · Birmingham, AL · Get directions →

    The goal of this study is to learn whether patients who have a genetic mutation in the genes that cause alpha 1 antitrypsin deficiency also have genetic variation in nearby genes that can increase risk for reduced immune function and respiratory infections. To investigate this hypothesis, we will compare immune responses to the 20-valent pneumococcal conjugate vaccine (PCV20, Pfizer) between participants who have one abnormal copy of the SERPINA1 gene and either no COPD exacerbations, vs those with 2 or more COPD exacerbations in the past year.

    ✓ Study care freePhase 4Ages 19+Learn more →
  • Heart / cardiovascular diseaseCOPD (chronic lung disease)

    Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF

    Testing a remote mindful program to increase daily steps in people with COPD and heart failure

    📍 VA Boston · Boston, MA · +1 more US site · Get directions →

    The goal of this fully-remote randomized controlled trial is to test the efficacy of Mindful Steps in facilitating physical activity compared to usual standard of care among 136 patients with COPD and/or HF. The main question it aims to answer is can this intervention promote physical activity as measured by daily step counts in sedentary patients with COPD and/or HF.

    ✓ Study care freeAges 40+Learn more →
  • Sickle cell disease

    Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)

    Tracking people with sickle cell trait to understand health patterns and complications

    📍 University of Alabama · Birmingham, AL · +9 more US sites · Get directions →

    The main purpose of this study is to create a longitudinal cohort of those with Sickle Cell Trait (SCT) to better understand the hematologic phenotype for those that carry HbS, assess for differences in those with varying quantities of HbS and assess for potential clinical complications of SCT.

    ✓ Study care freeAges 18+Learn more →
  • Parkinson's disease

    TURN-IT FOG: Improving Turning and Freezing of Gait in People With PD

    Testing rehabilitation programs to reduce freezing of walking in Parkinson’s

    📍 Arizona State University · Tempe, AZ · +1 more US site · Get directions →

    The goals of this clinical trial are to 1) learn how two different rehabilitation interventions for PD can reduce Freezing of Gait (FOG) in people with Parkinson's disease, as assessed by patients, clinicians, and wearable sensors, and 2) to explore whether two different rehabilitation intervention can reduce FOG and improve daily life mobility in people with FOG sufficiently to justify a clinical trial. Participants will: * Be randomly assigned to one of two intervention groups (turning-focused agility exercise or strength-based exercise) * Have one-on-one training sessions three times per week for 6 weeks * Perform in-lab assessments before beginning and after completing the study intervention * Use wearable mobility sensors during daily life to measure their walking and balance

    ✓ Study care freeAges 50–80Learn more →
  • Multiple sclerosis (MS)

    Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation

    Testing whether a low-level brain electric stimulation device can improve memory word recall in

    📍 The University of Texas at Dallas · Richardson, TX · Get directions →

    The purpose of the study is to test whether low level electric stimulation, called transcranial Direct Current Stimulation (tDCS), on the part of the brain (i.e., presupplementary motor area) thought to aid in memory will improve verbal retrieval in multiple sclerosis patients. The primary outcome measures are neuropsychological assessments of verbal retrieval, and the secondary measures are neuropsychological assessments of other cognitive abilities and electroencephalography (EEG) measures.

    ✓ Study care freeAges 18–65Learn more →
  • Dementia / Alzheimer'sParkinson's disease

    Phase 2 Trial of Tributyrin in People With Parkinson's Disease and Cognitive Impairments

    Testing whether a tributyrin supplement helps memory, thinking, and balance in adults with Parkinson

    📍 Domino's Farms · Ann Arbor, MI · Get directions →

    The goal of this clinical trial is to learn if taking a tributyrin supplement works to improve memory and thinking and walking and balance in adults with Parkinson disease Parkinson disease dementia. It will also learn about the safety of tributyrin supplementation.

    ✓ Study care freePhase 1Ages 45+Learn more →
  • Heart / cardiovascular diseaseCOPD (chronic lung disease)

    Passive Heat Therapy for People With COPD

    Testing whether a 45-minute hot-water footbath improves blood flow in people with COPD

    📍 University of British Columbia · Kelowna, British Columbia · Get directions →

    People with Chronic Obstructive Pulmonary Disease (COPD) often develop high blood pressure and heart disease due to their sedentary lifestyle and difficulty exercising. The investigators will test if heating can mimic the health benefits of exercise by monitoring the increase in leg blood-flow using ultrasound during a 45-minute hot-water footbath.

    ✓ Study care freeAges 40+Learn more →
  • Parkinson's disease

    Effects of RAS on Gait in PD Patients With DBS

    Testing how rhythm cues affect walking in people with Parkinson’s on and off DBS

    📍 Johns Hopkins School of Medicine · Baltimore, MD · Get directions →

    Participants will be asked to walk along with the metronome beats (RAS) during the participants' stimulation state (ON or OFF) for four minutes for each state. The researcher will collect the gait parameters (cadence, velocity, and stride length) of patients before, during, and after RAS in both DBS ON and OFF states.

    ✓ Study care freeAges 18–89Learn more →
  • Parkinson's disease

    Virtual tES Device Treatment for Parkinson's Disease Motor Symptoms

    Testing a non-invasive brain stimulation device to improve Parkinson’s movement problems

    📍 U LLC Headquarters · Cleveland, OH · Get directions →

    This study tests a new, non-invasive brain stimulation device called Sphere V3.0 to help improve movement problems in people with Parkinson's disease. The device delivers gentle electrical signals to the scalp using small electrodes placed on the head.

    ✓ Study care freePhase 1Ages 18–80Learn more →
  • Parkinson's disease

    Sleep-specific DBS Therapy in Parkinson's Disease

    Testing how deep brain stimulation affects sleep problems in Parkinson's

    📍 University Of Minnesota · Minneapolis, MN · Get directions →

    Sleep-wake disturbances are a major factor associated with reduced quality of life of individuals with Parkinson's disease (PD), a progressive neurological disorder affecting millions of people in the U.S and worldwide. The brain mechanisms underlying these sleep disorders, and the effects of therapeutic interventions such as deep brain stimulation on sleep-related neuronal activity and sleep behavior, are not well understood.

    ✓ Study care freeAges 21+Learn more →
  • Type 2 diabetesKidney disease

    Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

    Testing insulin re-sensitization in people with type 2 diabetes and chronic kidney disease

    📍 Arizona Kidney Disease and Hypertension Center · Phoenix, AZ · Get directions →

    The purpose of this research is to evaluate outcomes of physiologic insulin re-sensitization (PIR) in patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM).

    ✓ Study care freeAges 18+Learn more →
  • Sickle cell disease

    A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)

    Testing different doses of DISC-3405 to check safety in sickle cell disease

    📍 University of Alabama at Birmingham · Birmingham, AL · +6 more US sites · Get directions →

    This is an open-label, multicenter, within-participant dose-escalation study examining up to 3 dose levels of DISC-3405 and will assess the safety, tolerability, PK, and PD of DISC 3405 in participants with sickle cell disease.

    ✓ Study care freePhase 1Ages 18+Learn more →
  • Kidney disease

    Transcutaneous Auricular Vagus Nerve Stimulation Device in CKD Population

    Testing a noninvasive ear nerve stimulation device in people with chronic kidney disease

    📍 NYU Langone Health · New York, NY · Get directions →

    The purpose of this pilot interventional study is to collect preliminary data on the application of a transcutaneous auricular vagal nerve stimulation (taVNS) device in patients with chronic kidney disease (CKD). This data will enhance understanding of the short-term safety, tolerability and effects of this novel therapeutic approach in the setting of CKD.

    ✓ Study care freeAges 18–80Learn more →
  • COPD (chronic lung disease)

    📍 University of Alabama at Birmingham- Site Number : 8400003 · Birmingham, AL · +39 more US sites · Get directions →

    This is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig compared with placebo in adult participants (aged 40 to 80 years, inclusive) with inadequately controlled Chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype. Participation to the study consists of 3 periods: * Screening period of up to 4 weeks * Randomized intervention period of approximately 48 weeks * Follow-up period: Approximately 8 weeks The study duration will be up to 60 weeks.

    ✓ Study care freePhase 3Ages 40–80Learn more →
  • Parkinson's disease

    Cortical Correlates of Gait in Parkinson's Disease: Impact of Medication and Cueing

    Testing how personalized touch cues and Parkinson’s medication affect walking in people with

    📍 Oregon Health and Science University · Portland, OR · Get directions →

    The purpose of the study is to determine the effects of a novel, personalized, tactile cueing system on gait automaticity. The researchers hypothesized that step-synchronized tactile cueing will reduce prefrontal cortex activity (improve automaticity) and improve gait variability (as well as gait speed).

    ✓ Study care freeAges 45–85Learn more →
  • Kidney disease

    Transitioning to Home or In-center Dialysis

    Comparing quality of life for people choosing home versus in-center dialysis for advanced kidney

    📍 Hôpital Maisonneuve-Rosemont · Montreal, Quebec · Get directions →

    For people with advanced kidney disease, deciding which type of dialysis is best can be challenging. Studies have shown that quality of life is very important to patients.

    ✓ Study care freeAges 18+Learn more →
  • Parkinson's disease

    Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease

    Testing focused ultrasound on brain function and thinking in Parkinson's

    📍 The Regenesis Project · Santa Monica, CA · +1 more US site · Get directions →

    This is a pilot randomized, sham-controlled, double-blind, multi-center study evaluating the safety and preliminary effectiveness of the Gen0Bh Transcranial Focused Ultrasound System for the treatment of motor symptoms in individuals with idiopathic Parkinson's disease.

    ✓ Study care freeAges 22–80Learn more →
  • Parkinson's disease

    Targeted Motor Learning to Improve Gait for Individuals With Parkinson Disease

    Testing step training with a metronome to improve walking in people with Parkinson disease

    📍 University of North Carolina at Chapel Hill · Chapel Hill, NC · Get directions →

    The purpose of this research study is to determine how training to step with a metronome on both a treadmill, as well as overground, will influence the way that people with Parkinson disease walk. Using metronomes is commonly used in clinics, but the investigators will be using a combination of slow and fast frequencies to alter the way that people walk.

    ✓ Study care freeAges 50–80Learn more →
  • Kidney disease

    Effect of the Amplifi™ Vein Dilation System on Outflow Vein Dilation and AV Fistula Maturation (AMPLIFI-1)

    Testing a vein dilation device to help form an access for hemodialysis in kidney disease

    📍 Brigham Women's Hospital · Boston, MA · +1 more US site · Get directions →

    The AMPLIFI-1 Study is a prospective, multicenter pivotal clinical trial designed to evaluate the safety and effectiveness of the Amplifi™ Vein Dilation System in patients requiring distal arteriovenous fistula (AVF) creation for hemodialysis. The study has two cohorts: a randomized controlled (RC) cohort of patients with suitable cephalic veins (≥2.5 mm) randomized 2:1 to Amplifi treatment plus AVF creation versus standard AVF creation alone, and a non-randomized small vein cohort (NRC) of patients with borderline veins (1.7 to \<2.5 mm) treated with Amplifi therapy followed by AVF creation.

    ✓ Study care freeAges 18+Learn more →
  • Multiple sclerosis (MS)

    Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

    Testing remibrutinib in people with relapsing multiple sclerosis who switch from ocrelizumab versus

    📍 Perseverance Research Center · Scottsdale, AZ · +39 more US sites · Get directions →

    The purpose of this Phase 3b study is to assess the efficacy, safety and tolerability of remibrutinib after switching from ocrelizumab and compared to continuous ocrelizumab treatment, in patients living with relapsing multiple sclerosis (plwRMS).

    ✓ Study care freePhase 3Ages 40–70Learn more →
  • Parkinson's disease

    First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)

    Testing an experimental treatment for early Parkinson’s disease in adults

    📍 Montreal Neurological Institute and Hospital · Montreal, Quebec · Get directions →

    This study is researching an experimental drug called ALN-SNCA (called "study drug"). The study is focused on people with early Parkinson's disease, a disorder of the nervous system that affects movement.

    ✓ Study care freePhase 1Ages 50–80Learn more →
  • Parkinson's disease

    Colonic Tissue Biopsy Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis or REM Sleep Behavior Disorder

    Testing whether colon tissue can show a protein linked to Parkinson’s and REM sleep behavior

    📍 Digestive Disease Associates · Branford, CT · Get directions →

    The goal of this observational study is to learn whether tissue samples taken from the colon during routine colonoscopy can detect signs of Parkinson's disease or REM Sleep Behavior Disorder (RBD). The main question it aims to answer is: Can doctors find a protein called alpha-synuclein in colon tissue samples from people with Parkinson's disease and RBD?

    ✓ Study care freeAges 40–99Learn more →
  • Multiple sclerosis (MS)

    NARCOMS Registry: A Multiple Sclerosis Registry

    Tracking people with multiple sclerosis to learn about disease and treatment patterns over time for

    📍 UT Southwestern Medical Center · Dallas, TX · Get directions →

    This project is based on the idea that we can learn about the complexities of MS by following disease and treatment patterns in a large group of people over several years. The information gathered is used for research only.

    ✓ Study care freeAges 18+Learn more →
  • Parkinson's disease

    Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis

    Testing whether a low-dose seizure medicine can help Parkinson’s psychosis

    📍 Johns Hopkins · Baltimore, MD · Get directions →

    This clinical trial will test whether AGB101 (low-dose levetiracetam, 220 mg, extended release tablet) can improve symptoms of psychosis in Parkinson's disease. Participants will be asked to complete up to 5 in-person study visits over approximately 20 weeks.

    ✓ Study care freePhase 2Ages 40–85Learn more →
  • Kidney disease

    Lumbar Vein Embolization for Chronic Headaches With Nutcracker Physiology

    Studying whether blocking a lower back vein can treat chronic headaches

    📍 Mayo Clinic Florida · Jacksonville, FL · Get directions →

    The purpose of this research is to gather information on the safety and feasibility of coiling the lumbar vein for the treatment of chronic headaches in patients with Nutcracker physiology and retrograde lumbar vein flow with epidural venous plexus congestion. All patients are extensively evaluated by a headache trained Neurologist confirming high pressure headache refractory to other treatments.

    ✓ Study care freeAges 18+Learn more →
  • Parkinson's disease

    Changes in Movement, Fitness, and Quality of Life in People With Parkinson's Disease After Different Exercise Programs

    Testing how different exercise programs affect movement, fitness, and quality of life in Parkinson’s

    📍 University of Texas at El Paso Doctor of Physical Therapy and Movement Sciences Building · El Paso, TX · +1 more US site · Get directions →

    Parkinson's disease (PD) is a progressive neurological condition that can affect movement, balance, endurance, and overall quality of life. Exercise is widely recognized as one of the most effective non-pharmacological treatments to help people with PD maintain function and independence.

    ✓ Study care freeAges 50+Learn more →
  • Multiple sclerosis (MS)

    📍 Novartis Investigative Site · Darlinghurst, New South Wales · Get directions →

    This is an open-label, multi-center, non-confirmatory study to assess the safety, disease progression, and cellular kinetics following YTB323 administration to 28 participants with non-active Progressive Multiple Sclerosis (PMS). The study design utilizes an ascending single dose design consisting of 3 sentinel cohorts followed by an expansion cohort.

    ✓ Study care freePhase 1Ages 18–60Learn more →
  • Multiple sclerosis (MS)

    "Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS

    Testing a new way to track walking function in people with multiple sclerosis using patient-made

    📍 University of California, San Francisco · San Francisco, CA · Get directions →

    The goal of this observational study is to validate a novel, cost-effective method for real-world assessment using patient-acquired "selfie" videos in people with multiple sclerosis. The investigators aim to prove the feasibility and validity of monitoring walking changes remotely through a truly patient-centered, low-burden, low-cost approach.

    ✓ Study care freeAges 18+Learn more →
  • Heart / cardiovascular diseaseKidney disease

    The Impact of Renal Transplant on Coronary Microvascular Function Among Patients With Advanced Chronic Kidney Disease

    Studying how kidney transplant affects tiny-heart-vessel blood flow in people with advanced chronic

    📍 Brigham and Women's Hospital · Boston, MA · Get directions →

    People with chronic kidney disease (CKD) often experience faster aging of the heart and blood vessels, which raises the risk of heart problems beyond traditional factors like high blood pressure or cholesterol. One early sign is reduced blood flow in the tiny vessels that supply the heart, measured by a positron emission tomography (PET) scan using a marker called myocardial flow reserve (MFR).

    ✓ Study care freeAges 18+Learn more →
  • Multiple sclerosis (MS)

    Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

    Testing a modified ublituximab treatment for relapsing multiple sclerosis

    📍 TG Therapeutics Investigational Trial Site · Birmingham, AL · +34 more US sites · Get directions →

    The primary purpose of this phase 3b study is to assess the efficacy of a modified regimen of ublituximab in participants with relapsing multiple sclerosis (RMS) as measured by T1 Gadolinium (Gd)-enhancing lesions in Part A; PK in Part B along with efficacy of ublituximab as measured by T1 Gd-enhancing lesions in participants who had a suboptimal experience on prior anti-CD20 therapy in Part C. The study consists of 3 parts: Part A is single-armed and open-label, Part B is randomized, double-blind, placebo-controlled, and Part C is single-armed and open-label.

    ✓ Study care freePhase 3Ages 18–65Learn more →
  • Kidney disease

    Pragmatic Randomised Trial of High Or Standard PHosphAte Targets in End-stage Kidney Disease (PHOSPHATE)

    Testing whether aiming for lower blood phosphate helps people with end-stage kidney disease

    📍 Royal Prince Alfred Hosptial · Camperdown, New South Wales · Get directions →

    During end-stage kidney disease, clinical guidelines suggest reducing elevated phosphate levels in the blood. However, the effect of lowering blood phosphate levels on important patient-centred outcomes has never been tested.

    ✓ Study care freeAges 18+Learn more →
  • High blood pressureKidney disease

    📍 Research Site · Surprise, AZ · +17 more US sites · Get directions →

    International, Multicenter and Double-Blind study. The purpose is to measure the effect of baxdrostat in combination with dapagliflozin compared with baxdrostat/placebo on albuminuria, as well as safety, in participants with chronic kidney disease and high blood pressure.

    ✓ Study care freePhase 2Ages 18+Learn more →
  • Parkinson's disease

    A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

    Testing a treatment in people with early Parkinson’s disease who have an LRRK2 gene test result

    📍 Banner Sun Health Research Institute · Sun City, AZ · +39 more US sites · Get directions →

    The goal of this Phase 2 clinical trial is to investigate the efficacy and safety of NEU-411 in men and women aged 40-80 years with early Parkinson's Disease (PD) who have predicted elevations in the activity of the "leucine-rich repeat kinase 2" ("LRRK2" for short) pathway based on their genetic profile. A DNA test will be used to identify the "LRRK2-driven" population with predicted elevation in the LRRK2 pathway.

    ✓ Study care freePhase 2Ages 40–80Learn more →
  • COPD (chronic lung disease)

    A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

    Testing the long-term safety of astegolimab in people with COPD

    📍 UAB Lung Health Center · Birmingham, AL · +39 more US sites · Get directions →

    The purpose of this study is to assess the long-term safety and to explore the efficacy of astegolimab in participants with chronic obstructive pulmonary disease (COPD) who have completed the 52-week placebo-controlled treatment period in parent studies GB43311 or GB44332.

    ✓ Study care freePhase 3Ages 40–90Learn more →
  • Multiple sclerosis (MS)

    A Single-Center Study to Characterize the Safety and Efficacy of Ublituximab in Older Adults With Relapsing Forms of Multiple Sclerosis (RMS)

    Testing how safe ublituximab is for older adults with multiple sclerosis, by tracking infection

    📍 Neurology Center of New England P.C. · Foxborough, MA · Get directions →

    The purpose of this study is to evaluate the safety of ublituximab use in the older MS adult population, as measured by incidence of infection rate

    ✓ Study care freeAges 55–80Learn more →
  • Kidney disease

    Precision Medicine Approaches to Renal Osteodystrophy

    Testing better ways to measure bone changes in people with chronic kidney disease

    📍 Washington University in St. Louis (WashU) · St Louis, MO · Get directions →

    Treatment of renal osteodystrophy is impeded by the lack of practical and accurate tools to determine underlying bone turnover. Gold standard bone biopsy is not practical in the clinic for the vast majority of kidney disease patients and parathyroid hormone and bone alkaline phosphatase have insufficient accuracy for turnover type to safely and confidently guide treatment of renal osteodystrophy.

    ✓ Study care freeAges 18+Learn more →
  • Multiple sclerosis (MS)

    An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

    Testing safety of a new immune cell therapy in adults with multiple sclerosis

    📍 Research Site · Tucson, AZ · +8 more US sites · Get directions →

    This trial is a Phase 1b, open-label, multi-center, clinical study of AZD0120, a BCMA/CD19 dual targeting CAR+ T-cell therapy, to evaluate the safety and tolerability in adult participants with Multiple Sclerosis.

    ✓ Study care freePhase 1Ages 18–60Learn more →
  • Parkinson's disease

    Effects Of Osteopathic Manipulative Medicine(OMM) On Lower Extremity Muscle Characteristics In Parkinson's Disease(PD) Patients

    Testing osteopathic treatment to see how it affects leg muscles in Parkinson’s

    📍 NYIT College of Osteopathic Medicine · Old Westbury, NY · Get directions →

    The purpose of the study is to investigate the effects that Osteopathic Manipulative Medicine has on lower extremity muscle characteristics in PD. Muscle stiffness, range of motion, and gait will be measured.

    ✓ Study care freeAges 18+Learn more →
  • Multiple sclerosis (MS)

    Ublituximab (Briumvi) for Early Forms of Relapsing Multiple Sclerosis

    Testing safety of a twice-yearly medicine for early relapsing MS

    📍 Northwestern Memorial Hospital · Chicago, IL · Get directions →

    In this prospective, open-label, single-arm, single-institution trial, the investigators will accomplish the following two aims: 1. study the safety and tolerability of Ublituximab (Briumvi) twice annually in participants with early MS over a treatment observation period of \~12 months.

    ✓ Study care freePhase 4Ages 18–70Learn more →
  • Parkinson's disease

    📍 University of Kentucky · Lexington, KY · Get directions →

    The investigators propose a Phase I single surgical-center, double-blinded randomized parallel clinical trial involving bilateral autologous peripheral nerve tissue (PNT) delivery into the NBM or the alternate target also affecting cognition in this population, the substantia nigra (SN), to address "repair cell" support of these areas. Twenty-four participants with idiopathic Parkinson's Disease (PD) who have selected, qualified and agreed to receive as standard of care deep brain stimulation (DBS) will be enrolled and randomly allocated to receive bilateral PNT deployment to either the NBM or SN at the time of DBS surgery.

    ✓ Study care freePhase 1Ages 45–75Learn more →
  • High blood pressureCOPD (chronic lung disease)

    Phenotyping Resting and Exertional Right Ventricular Dysfunction Among Patients With Chronic Obstructive Pulmonary Disease

    Studying how the right side of the heart works at rest and during exercise in people with COPD

    📍 University of Colorado Anschutz Medical Campus · Aurora, CO · Get directions →

    This study plans to learn about heart function among individuals with chronic obstructive pulmonary disease (COPD). In particular, the investigators want to understand the different patterns of right ventricular response during rest and moderate- vs high-intensity exercise.

    ✓ Study care freeAges 40+Learn more →
  • Parkinson's disease

    Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease

    Comparing lower versus higher amounts of light exercise for Parkinson’s

    📍 Atlanta VA Medical and Rehab Center, Decatur, GA · Decatur, GA · Get directions →

    Veterans with mid to later stage Parkinson's disease (PD) may not be able to work out as hard as they need to, to prevent brain cell loss. Maybe they could work out longer and more frequently to make up for this during their good times and good weeks and then rest during the bad weeks.

    ✓ Study care freeAges 40+Learn more →
  • Kidney disease

    CommunityRx-Kidney Health

    Testing a new health information program to help manage kidney disease in rural North Carolina

    📍 Goshen Medical Center · Beulaville, NC · Get directions →

    In the United States, the burden of chronic kidney disease (CKD) rests disproportionately on rural communities. This study evaluates the implementation and effectiveness of CommunityRx-Kidney Health (CRx-K); this health information technology intervention integrates medical, social, and self-care resources to improve CKD management in rural eastern North Carolina.

    ✓ Study care freeAges 18+Learn more →
  • Parkinson's disease

    Apathy in Parkinson Disease TMS Study

    Testing non-invasive brain stimulation targets for apathy in Parkinson disease

    📍 UNC-Chapel Hill, Cassidy Lab · Chapel Hill, NC · Get directions →

    The goal of this clinical trial is to develop non-invasive brain stimulation targets for the treatment of apathy, or motivation problems, in Parkinson Disease. The main questions the study aims to answer are: 1.

    ✓ Study care freeAges 55–80Learn more →
  • Parkinson's disease

    Exercise & Brain Energetics in PD

    Testing whether exercise changes brain energy use in Parkinson’s disease

    📍 Pacific Parkinson's Research Centre · Vancouver, British Columbia · Get directions →

    There is increasing evidence that the usage and delivery of energy to the brain, known as brain energetics, is altered in people with Parkinson's disease (PD). This project will explore whether exercise has a positive impact on brain energetics using functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) brain scanning in PD subjects.

    ✓ Study care freeAges 40–80Learn more →
  • Multiple sclerosis (MS)

    Effect of Cooling on Balance Performance in Multiple Sclerosis

    Studying whether cooling affects balance in people with multiple sclerosis

    📍 Hunter College, Physical Therapy Department, City University of New York · New York, NY · Get directions →

    The goal of this observational study to examine the effects of cooling on balance in persons with Multiple Sclerosis. Persons with Multiple Sclerosis frequently have problems with balance leading to falls and related injuries, as well as avoidance of activities that may challenge balance.

    ✓ Study care freeAges 18–75Learn more →
  • Heart / cardiovascular diseaseKidney disease

    A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

    Testing whether orforglipron changes heart outcomes in adults with heart disease and/or kidney

    📍 Instituto de Investigaciones Clínicas Bahia Blanca · Bahía Blanca, · Get directions →

    The purpose of this study is to measure cardiovascular outcomes with orforglipron compared with placebo in participants with atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD). Participation in the study will last about 5 years.

    ✓ Study care freePhase 3Ages 50+Learn more →
  • Showing the first 60 of 834. Add filters or a location to narrow down.